PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (VINC) (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...
Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. Global cost pressures and a fast-changing political and ...
Oracle Argus Safety processes 10 million adverse event cases annually for pharmaceutical companies worldwide, according to Oracle. Yet module-specific issues continue to delay regulatory submissions, ...
The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...
For many Americans, pharmaceutical drugs are too expensive—and thanks to a system of complex and tedious bureaucracy, any effort for meaningful reform has been futile. Cost Plus Drugs wants to change ...
Royalty Pharma plc announced that its shareholders overwhelmingly approved the acquisition of its external manager, achieving 99.9% support during the 2025 Annual General Meeting. This transition to ...
SCOTTSDALE, Ariz., Oct. 29, 2025 /PRNewswire/ -- CustomerInsights.AI (CIAI) today announced the launch of ciATHENA's Market Mix Modeling (MMM) use case: the pharma industry's first Agentic AI-powered ...
Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. Mar 12, 2025, 03:13pm EDT Photo of a worker sitting in an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback